TokenPost·
Merck, Eli Lilly Enter Earnings Reports With Declines Expected
Analysts project Merck’s earnings per share at $2.09, down 19% from a year earlier.
More news
- TokenPostHarvey Launches Claude Intake Tool for Employee Legal Requests
- TokenPostMeta May Delay Business Terms as Norway Court Bars Irish Unit From Implementing Them
- TokenPostNvidia Adds 40-Language Speech Model and GPU Controls to RTX Spark
- TokenPostCanadian Pacific Kansas City Keeps Quarterly Dividend at C$0.268
- Crypto BriefingSpain rail crash kills 68, impacts Sánchez’s reelection campaign
- TokenPostVanguard S&P 500 ETF (VOO) Rises 0.21% as MACD Reads -0.16